EyePoint (EYPT) Non Operating Income (2010 - 2026)
EyePoint (EYPT) reported Non Operating Income of $2.3 million for Q1 2026, down 35.64% on a YoY basis from $3.6 million in Q1 2025, and down 19.78% sequentially from $2.9 million in Q4 2025.
EyePoint (EYPT) Non Operating Income (2010 - 2026) Analysis & Trends
EyePoint (EYPT) has 15 years of Non Operating Income data on file, last reported at $2.3 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 35.64% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $10.5 million (down 28.79% YoY), and the FY2025 full-year result was $11.8 million, down 22.04% from the prior year.
- Non Operating Income declined to $2.3 million in Q1 2026, from $2.9 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $4.0 million in Q1 2024 to a low of -$2.7 million in Q1 2022.
- A 5-year average of $1.8 million and a median of $2.3 million in 2023 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income tumbled 119.61% in 2022 and soared 8218.18% in 2023, its largest moves.
- Tracing EYPT's Non Operating Income over 5 years: stood at $283000.0 in 2022, then soared by 726.15% to $2.3 million in 2023, then soared by 68.09% to $3.9 million in 2024, then retreated by 25.65% to $2.9 million in 2025, then slipped by 19.78% to $2.3 million in 2026.
- Business Quant data shows EYPT's Non Operating Income at $2.3 million in Q1 2026, $2.9 million in Q4 2025, and $2.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | 2.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.34 Mn |
| Dec 31, 2025 | 2.92 Mn |
| Sep 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.89 Mn |
| Mar 31, 2025 | 3.64 Mn |
| Dec 31, 2024 | 3.93 Mn |
| Sep 30, 2024 | 3.39 Mn |
| Jun 30, 2024 | 3.72 Mn |
| Mar 31, 2024 | 4.04 Mn |
| Dec 31, 2023 | 2.34 Mn |
| Sep 30, 2023 | 1.79 Mn |
| Jun 30, 2023 | -159,000.00 |
| Mar 31, 2023 | 390,000.00 |
| Dec 31, 2022 | 283,000.00 |
| Sep 30, 2022 | -22,000.00 |
| Jun 30, 2022 | -190,000.00 |
| Mar 31, 2022 | -2.69 Mn |
| Dec 31, 2021 | -1.38 Mn |
| Sep 30, 2021 | -1.38 Mn |
| Jun 30, 2021 | 969,000.00 |